Ago Research Gmbh
Clinical trials sponsored by Ago Research Gmbh, explained in plain language.
-
New drug combo could boost ovarian cancer surgery success
Disease control Recruiting nowThis study is for people with advanced ovarian cancer who are scheduled for surgery. It tests whether taking a drug called olaparib alone or with another drug called durvalumab for a short time before surgery is safe and practical. The goal is to see if this approach can be done …
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated May 15, 2026 12:01 UTC
-
New drug combo offers hope for Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis study tests whether two drugs, pembrolizumab and lenvatinib, can shrink tumors in people with vulvar cancer that has come back, spread, or cannot be removed by surgery or radiation. About 42 participants will receive the drug combination. The goal is to see how many patients…
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated May 15, 2026 11:56 UTC